ArticleNature communications2026
Neutrophil extracellular traps promote liver metastasis by impairing NK cell-dependent tumor surveillance via CCDC25.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Tumor metastasis requires constant crosstalk between primary tumor cells and immune cells in distant organs, yet how this interaction shapes the evolving immune landscape of metastatic sites remains unclear. Here, using longitudinal single-cell RNA sequencing in a 4T1 orthotopic breast cancer model, we observe a progressive infiltration of neutrophils, robust NETosis and an immunosuppressive niche during metastatic progression in the liver. Through multiple in vivo models, we determine that macrophage-dependent neutrophil extracellular trap (NET) formation serves as a potent driver of liver metastasis. Mechanistically, extracellular NET-derived DNA is sensed by the transmembrane protein coiled-coil domain containing 25 (CCDC25) on natural killer (NK) cells, and the NET-CCDC25 interaction impairs NK cell surveillance by downregulating multiple activating receptors, including NKG2D, NKp46, NKp44, via the CCDC25-ILK-STAT3 axis. In clinical metastatic liver samples, a higher level of NET expression is associated with NK cell dysfunction. Overall, our findings identify CCDC25 as a potential "innate immune checkpoint" on NK cells, revealing a promising therapeutic strategy to reactivate NK cell function to inhibit liver metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.